Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-Induced Movement Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02657681
What this trial is testing

Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)

Who this might be right for
Dyskinesia, Medication-InducedParkinson's Disease
Fundación de investigación HM 50
Not applicableStudy completedNCT03287778
What this trial is testing

Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia

Who this might be right for
Tardive DyskinesiaAntipsychotic Agents
University of North Carolina, Chapel Hill 17
Post-approval studies (Phase 4)Study completedNCT00164242
What this trial is testing

Treatment of Tardive Dyskinesia With Galantamine

Who this might be right for
Tardive Dyskinesia
Caroff, Stanley N., M.D. 36
Not applicableNot Yet RecruitingNCT06218719
What this trial is testing

Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients

Who this might be right for
Tardive Dyskinesia
Power Life Sciences Inc. 500
Post-approval studies (Phase 4)Looking for participantsNCT07105111
What this trial is testing

Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Neurocrine Biosciences 100
Large-scale testing (Phase 3)Study completedNCT03176771
What this trial is testing

Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Tanabe Pharma Corporation 256
Testing effectiveness (Phase 2)Looking for participantsNCT07365462
What this trial is testing

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 100
Testing effectiveness (Phase 2)UnknownNCT01081275
What this trial is testing

Improving Hand Use in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Multiple Sclerosis Society 66
Testing effectiveness (Phase 2)Looking for participantsNCT06731868
What this trial is testing

Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia (TD)
Luye Pharma Group Ltd. 120
Early research (Phase 1)Study completedNCT00255879
What this trial is testing

Movement Disorders Caused by Antipsychotic Drugs in Older Patients

Who this might be right for
Dyskinesia, Drug-Induced
University of California, San Diego 250
Testing effectiveness (Phase 2)Study completedNCT01733121
What this trial is testing

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 102
Testing effectiveness (Phase 2)WithdrawnNCT02064010
What this trial is testing

Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia

Who this might be right for
Drug-induced Tardive Dyskinesia
Synchroneuron Inc.
Not applicableLooking for participantsNCT05317390
What this trial is testing

Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia

Who this might be right for
DystoniaDrug Induced DystoniaParkinson Disease+8 more
Massachusetts Eye and Ear Infirmary 1,000
Testing effectiveness (Phase 2)Study completedNCT01393600
What this trial is testing

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 37
Large-scale testing (Phase 3)Study completedNCT02736955
What this trial is testing

Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 161
Testing effectiveness (Phase 2)Study completedNCT00175955
What this trial is testing

Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

Who this might be right for
Dyskinesia, Medication-induced
UCB Pharma 70
Not applicableStudy completedNCT02950376
What this trial is testing

The Novel Addiction Assessment Study in Synthetic Drugs Addiction

Who this might be right for
Amphetamine Addiction
Shanghai Mental Health Center 1,500
Not applicableLooking for participantsNCT06949865
What this trial is testing

AI-Enhanced Optimization of Acute Levodopa Challenge Test

Who this might be right for
Vascular ParkinsonismDrug-induced ParkinsonismCorticobasal Degeneration (CBD)+4 more
Beijing Tiantan Hospital 2,000
Testing effectiveness (Phase 2)Study completedNCT05297201
What this trial is testing

Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia

Who this might be right for
Parkinson DiseaseDyskinesia, Medication-Induced
Celon Pharma SA 105
Post-approval studies (Phase 4)Study completedNCT00621998
What this trial is testing

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia

Who this might be right for
Neuroleptic-Induced Tardive Dyskinesia
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 60
Next Page